Cardiology

Late mortality mainly noncardiac for TAVR patients

(HealthDay)—For high-risk patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR), late mortality is mainly related to noncardiac causes, according to research published in the Oct. ...

Cardiology

Results of CLEAN-TAVI trial reported at TCT 2014

A first-of-its kind study found that using a cerebral protection device during transcatheter aortic valve replacement (TAVR) can significantly reduce the number and volume of cerebral lesions in high risk patients with severe ...

Cardiology

New heart valve shows high survival rates in study

Loyola University Medical Center is the only Chicago hospital participating in a landmark clinical trial of an artificial aortic heart valve that does not require open heart surgery.

Cardiology

Results of PARTNER I trial reported at TCT 2014

New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit, improved functional status, and resulted in a lower rate of repeat ...

page 16 from 19